48,851
edits
Jensflorian (talk | contribs) |
m (Primary biliary cholangitis (newer term - replaces 'primary biliary cirrhosis')) |
||
(52 intermediate revisions by 2 users not shown) | |||
Line 9: | Line 9: | ||
#Laboratory studies, e.g. CK. | #Laboratory studies, e.g. CK. | ||
#Nerve conduction and electromyography studies. | #Nerve conduction and electromyography studies. | ||
#Muscle biopsy. | #Muscle / nerve biopsy. | ||
===Clinical=== | ===Clinical=== | ||
Line 27: | Line 27: | ||
**Men: 24-195 unit/litre. | **Men: 24-195 unit/litre. | ||
**Women: 24-170 units/litre. | **Women: 24-170 units/litre. | ||
===Biopsy=== | |||
====Muscle biopsies==== | |||
Indications: | |||
* Weakness, Fatigue, Cramps | |||
* Myopathic EMG | |||
* Elevated CK | |||
Not indicated: Myasthenia gravis, myotonia | |||
* MRI to select ideal spots for biopsy. | |||
* In chronic diseases, select a '''moderately''' affected muscle. | |||
** Best specific muscles: Deltoid, Biceps, Quadriceps. | |||
** Avoid areas with previous EMG analysis. | |||
* Tissue should be sent fresh or frozen for analysis. | |||
** Freeze most tissue in isopentane (-160°C) immersed in liquid nitrogen. | |||
** Ultrastructural analyis might be required in some cases -> save something in 4% glutaraldehyde. | |||
* [[FFPE]] specimens unsuitable for enzymatic stains. | |||
** Useful for morphology of inflammatory cells. | |||
====Nerve biopsies==== | |||
* Nerve procession: 3 pieces | |||
** Frozen -> useful for acid phosphatase, congo etc.. | |||
** Formalin -> for IHC. | |||
** 4% Glutaraldehyde fixed -> for electron microscopy. | |||
====Skin biopsies==== | |||
* Punch biopsies (3mm) for small fiber neuropathy. | |||
** Paraformaldehyde-lysine-periodate -> for PGP9.5 immunofluorescence. | |||
=Muscle structure/histology= | =Muscle structure/histology= | ||
Line 40: | Line 69: | ||
**Nerve (surrounded by ''epineurium'') -> Fascicle (surrounded by ''perineurium'') -> Nerve fibre (surrounded by ''endoneurium''). | **Nerve (surrounded by ''epineurium'') -> Fascicle (surrounded by ''perineurium'') -> Nerve fibre (surrounded by ''endoneurium''). | ||
===Fibre types=== | ===Fibre=== | ||
[[File:1022 Muscle Fibers (small).jpg|500px|right]] | |||
====Fibre morphology==== | |||
*Small or large? | |||
**Related to age? Birth 15µm, 6yrs: 25-30µm, 12yrs: 45µm, adult: 50-60µm. | |||
*Round or angular? | |||
*Architecture: Normal, inclusions, nuclear internalization? | |||
*Pathology distribution: Absent, focal, uniform? | |||
**Pathologic material: Amyloid, Glycogen, Lipid? | |||
====Fibre types==== | |||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | |A11| | | | |A11 =Types }} | {{familytree | | | |A11| | | | |A11 =Types }} | ||
Line 47: | Line 86: | ||
{{familytree/end}} | {{familytree/end}} | ||
Type 1 - [[AKA]] slow twitch: | Type 1 - [[AKA]] slow twitch: | ||
*Predominantly oxidative metabolism, i.e. have lots of mitochondria. | *Predominantly oxidative metabolism, i.e. have lots of mitochondria. | ||
Line 99: | Line 137: | ||
| higher | | higher | ||
| lower | | lower | ||
|- | |||
| ATPase pH 9.4 stain | |||
| light brown | |||
| dark brown | |||
|} | |} | ||
</center> | </center> | ||
*Check for fibre type grouping or fibre type predominance. | |||
===Normal findings=== | ===Normal findings=== | ||
Line 131: | Line 176: | ||
*Ragged red fibres = mitochondrial pathology. | *Ragged red fibres = mitochondrial pathology. | ||
**Image: [http://moon.ouhsc.edu/kfung/jty1/NeuroTest/Q71-Ans.htm Ragged red fibres (ouhsc.edu)]. | **Image: [http://moon.ouhsc.edu/kfung/jty1/NeuroTest/Q71-Ans.htm Ragged red fibres (ouhsc.edu)]. | ||
*Rimmed vacuoles = [[inclusion body myositis]]. | *Vacuoles | ||
**Acid maltase positive = lysosomal vacuoles. | |||
**Rimmed vacuoles = [[inclusion body myositis]]. | |||
**Freezing artifacts (clear). | |||
*PAS +++ = [[glycogen storage disease]]. | *PAS +++ = [[glycogen storage disease]]. | ||
* | *Nemaline rods = [[nemaline myopathy]] | ||
**Image: [http://commons.wikimedia.org/w/index.php?title=File:Biopsy nemaline myopathy gomori.jpg] | |||
*Cores - central pale area along length of fibres in NADH stain = central core disease. | |||
**Image: [http://commons.wikimedia.org/w/index.php?title=File:Central core disease NADH stain.jpg]. | |||
Others: | Others: | ||
*Annular myofibrils ("ringbinden") = myopathic: Regeneration, myotonic dystrophy, tenotomy. Found in approx. 3% of unselected cases. | |||
Images: [http://frontalcortex.com/?page=image&topic=1&qid=987] - HE, NADH or MAD stains are useful. | |||
*Target fibre - "hole in middle of myofibres" = neurogenic. | *Target fibre - "hole in middle of myofibres" = neurogenic. | ||
**Images: [http://commons.wikimedia.org/w/index.php?title=File:Denervation_atrophy_-_very_high_mag.jpg Target fibres - very high mag. (WC)], [http://commons.wikimedia.org/wiki/File:Denervation_atrophy_-_sdh_-_very_high_mag.jpg Target fibres - SDH stain - very high mag. (WC)]. | **Images: [http://commons.wikimedia.org/w/index.php?title=File:Denervation_atrophy_-_very_high_mag.jpg Target fibres - very high mag. (WC)], [http://commons.wikimedia.org/wiki/File:Denervation_atrophy_-_sdh_-_very_high_mag.jpg Target fibres - SDH stain - very high mag. (WC)]. | ||
* | *Regenerative fibres = large nuclei, basophilic cytoplasm (incr. protein synthesis, incr. RNA). | ||
===Approach=== | ===Approach=== | ||
General: | General: | ||
#Size variation - in groups (neurogenic) vs. singular (myogenic). | *Neurogenic or myopathic? | ||
*Acute or chronic? | |||
Check: | |||
#Size variation - in groups (neurogenic, Dystrophinopathies) vs. singular scattered (myogenic, acute neurogenic). | |||
#Shape - angulated (neurogenic) vs. round (myogenic). | #Shape - angulated (neurogenic) vs. round (myogenic). | ||
#Position of nuclei - peripheral (normal); central (myogenic; centronuclear myopathy<ref>URL: [http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html]. Accessed on: 26 October 2010.</ref>). | #Position of nuclei - peripheral (normal); central (myogenic; centronuclear myopathy<ref>URL: [http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html]. Accessed on: 26 October 2010.</ref>). | ||
#[[Necrosis]] - suggests myogenic. | #[[Necrosis]] & regeneration - suggests acute myogenic. | ||
#Fibrosis - suggests myogenic. | #Fibrosis - suggests chronic myogenic. | ||
#Inflammation - suggest myogenic vs. systemic inflammatory. | #Inflammation - suggest myogenic vs. systemic inflammatory. | ||
#*Lymphocytes, macrophages, eosinophils - or even neoplastic? | |||
#Fibre type predominance - suggest congenital myopathy (esp. in small type 1 fibres), demyelinating neuropathy. | |||
Other: | Other: | ||
#Obvious abnormality vs. minimal change. | #Obvious abnormality vs. minimal change. | ||
#Diffuse vs. focal change. | #Diffuse vs. focal change. | ||
#Pathology in adjacent vessels or connective tissue. | |||
==Processing of muscle biopsies== | ==Processing of muscle biopsies== | ||
Line 247: | Line 305: | ||
|- | |- | ||
| H&E stain | | H&E stain | ||
| routine | | routine, fibre size, shape, nuclei | ||
| [http://www.rvc.ac.uk/Research/Labs/NeuroLab/images/HE.jpg H&E]<ref>URL: [http://www.rvc.ac.uk/Research/Labs/NeuroLab/MuscleBiopsy.cfm http://www.rvc.ac.uk/Research/Labs/NeuroLab/MuscleBiopsy.cfm]. Accessed on: 26 October 2010.</ref>, [http://commons.wikimedia.org/wiki/File:Denervation_atrophy_-_very_high_mag.jpg H&E (WC)] | | [http://www.rvc.ac.uk/Research/Labs/NeuroLab/images/HE.jpg H&E]<ref>URL: [http://www.rvc.ac.uk/Research/Labs/NeuroLab/MuscleBiopsy.cfm http://www.rvc.ac.uk/Research/Labs/NeuroLab/MuscleBiopsy.cfm]. Accessed on: 26 October 2010.</ref>, [http://commons.wikimedia.org/wiki/File:Denervation_atrophy_-_very_high_mag.jpg H&E (WC)] | ||
|- | |- | ||
Line 271: | Line 329: | ||
|- | |- | ||
| NADH-TR | | NADH-TR | ||
| should have "checkerboard <br>pattern" in normal; <br>type 1 fibres = light blue, <br>type 2 fibres = white | | good for cores or tubular aggregates, should have "checkerboard <br>pattern" in normal; <br>type 1 fibres = light blue, <br>type 2 fibres = white | ||
| | | [https://commons.wikimedia.org/wiki/File:Cell_sample_of_muscle_tissue_with_central_core_disease_(stained_for_contrast).jpg] | ||
|- | |||
| Myoadenylate deaminase | |||
| Normal: positive, AMPDA deficiency: negative | |||
| [https://commons.wikimedia.org/wiki/File:MAD_deficiency_enzymatic.jpg MAD deficiency] | |||
|- | |||
| Acid phosphatase | |||
| Histiocytes/Macrophages, Lysosomal storage, Lipofuscin | |||
| | |||
|- | |||
| Cytochrome oxidase | |||
| Mitochondrial pathology | |||
| [https://commons.wikimedia.org/wiki/File:Cox-deficient_fibers_in_mitochondrial_myopathy.jpg COX deficiency] | |||
|} | |} | ||
Line 643: | Line 713: | ||
===General=== | ===General=== | ||
Etiology:<ref>{{Cite journal | last1 = Prieto-González | first1 = S. | last2 = Grau | first2 = JM. | title = Diagnosis and classification of granulomatous myositis. | journal = Autoimmun Rev | volume = 13 | issue = 4-5 | pages = 372-4 | month = | year = | doi = 10.1016/j.autrev.2014.01.017 | PMID = 24424169 }}</ref> | Etiology:<ref>{{Cite journal | last1 = Prieto-González | first1 = S. | last2 = Grau | first2 = JM. | title = Diagnosis and classification of granulomatous myositis. | journal = Autoimmun Rev | volume = 13 | issue = 4-5 | pages = 372-4 | month = | year = | doi = 10.1016/j.autrev.2014.01.017 | PMID = 24424169 }}</ref> | ||
* [[Sarcoidosis]] | * [[Sarcoidosis]]. | ||
* Idiopathic | * Idiopathic. | ||
* Infectious ([[Tuberculosis]], Syphillis, Brucellosis | * Infectious ([[Tuberculosis]], Syphillis, Brucellosis. | ||
* Foreign-body reaction | * Foreign-body reaction. | ||
* [[Thymoma]] - myasthenia gravis | * [[Thymoma]] - myasthenia gravis. | ||
* [[Lymphoma]] - paraneoplastic | * [[Lymphoma]] - paraneoplastic. | ||
* [[Primary biliary | * [[Primary biliary cholangitis]]. | ||
<gallery> | <gallery> | ||
Line 655: | Line 725: | ||
File:Granulomatous myositis.jpg | Granulomatous myositis ([[H&E]]) | File:Granulomatous myositis.jpg | Granulomatous myositis ([[H&E]]) | ||
</gallery> | </gallery> | ||
==Spinal muscular atrophy== | |||
* Autosomal recessive disease by SMN1 gene deletion on chromosome 5q. | |||
* Centromeric gene copy (SMN2) whose product can mitigate disease severity. | |||
* Variability in severity and age of onset of disease (SMA type 1-4). | |||
* Neurogenic muscle atrophy, weakness, loss of reflexes, tongue fasciculation and tremor. | |||
** Usu. groups of atrophic fibers. | |||
** Few compensatorirc hypertrophic fibers. | |||
===Diagnostic relevance=== | |||
* Antisense-oligonucleotide that increase full-length protein product derived from SMN2 (Nusinersen). | |||
* Gene transfer with scAAV9-SMN (Zolgensma). | |||
==Metabolic myopathy== | ==Metabolic myopathy== | ||
Line 677: | Line 759: | ||
*A type of congenital myopathy. | *A type of congenital myopathy. | ||
*Paediatric thingy. | *Paediatric thingy. | ||
*May appear secondary in other lesions. | |||
*Rods are seen in trichrome stain | *Rods are seen in trichrome stain | ||
<gallery> | <gallery> | ||
File:Biopsy nemaline myopathy gomori.jpg | Nemaline rods (Trichrom Gomöri). | File:Biopsy nemaline myopathy gomori.jpg | Nemaline rods (Trichrom Gomöri). | ||
File:Congenital nemaline myopathy.jpg | Congenital nemaline myopathy (Trichrom Gomöri). | |||
</gallery> | |||
==Central core myopathy== | |||
===General=== | |||
*Floppy infant, but stable clinial course. | |||
*Autosomal dominant inheritance. | |||
**Mutation in RYR1 | |||
**Predisposition for malignant hyperthermia. | |||
*Normal CK levels. | |||
*Non-pathologic EMG. | |||
*Cores visile in NADH staining. | |||
**Mostly centrally, but can be eccentric. | |||
<gallery> | |||
File:Central core disease NADH stain.jpg | Cores (NADH stain). | |||
File:Cell sample of muscle tissue with central core disease (stained for contrast).jpg | Cores (NADH TR stain). | |||
</gallery> | </gallery> | ||
Line 735: | Line 837: | ||
===General=== | ===General=== | ||
*Most common biopsy: sural nerve. | *Most common biopsy: sural nerve. | ||
**Approx. 20-30% of the biopsies are diagnostic or may alter treatment decisions. | |||
** Far less common: Superficial peroneal nerve. | |||
*Metabolic, toxic and nutritional causes account for 50% of neuropathies. | |||
*Inflammatory neuropathies (mostly GBS, CIDP or vasculitis): 10-20%. | |||
*Familial neuropathy: 10-20%. | |||
*Neoplasm-associated neuropathy: 5-10%. | |||
===Nerve structure=== | |||
*Nerve (surrounded by epineurium). | |||
*Fascicle (surrounded by perineurium). | |||
** Usu 6-15 fascicles in sural nerve. | |||
*Nerve fibre (surrounded by endoneurium). | |||
**Myelinated axons. | |||
**Unmyelinated axons and their Schwann cells together are called Remak bundles. | |||
Epineurium: | |||
* Capillaries, arterioles and venules. | |||
* Fibroblasts (CD34+/-ve, EMA-ve, S100-ve). | |||
* Macrophages (CD68+ve, CD168+ve). | |||
* Mast cells (metachromatic granules). | |||
* Leukocytes (usu. less than 10 CD3+ve Lymphocytes/mm²). | |||
* Pacinian corpuscles (no pathological relevance). | |||
Perineurium: | |||
* Fascicles may separated by perineurial septae. | |||
*Occasional perineurial calcifications (no pathological relevance). | |||
*Renaut bodies (subperineurial whorled structures consisting of fibroblasts). | |||
<gallery> | |||
Image:N_renaut_body_semithin.jpg|Renaut body in a fascicle. | |||
File:Pacinian Corpuscle (36298105211).jpg|Pacinian corpuscle. | |||
</gallery> | |||
===Stains=== | ===Stains=== | ||
Line 744: | Line 878: | ||
*Myelin = red. | *Myelin = red. | ||
Toluidine blue staion: | |||
*Plastic embedded semithin sections (1µm). | |||
===Artifacts=== | |||
*Myelin splits: stretching. | |||
*Neurokeratin: Formalin fixation (longitudinal: "herringbone", cross section: "wagon-wheels"). | |||
*Dark staining myelin: crushing. | |||
*Pale expanding myelin sheets: delayed fixation. | |||
*Uneven myelin staining: osmication problems. | |||
*Shrunken crescentic fascicles: Hyperosmolarity. | |||
===Reactive changes=== | |||
* Traumatic [[Peripheral_nerve_sheath_tumours#Traumatic_neuroma|Neuroma]] | |||
* Pacinian [[Neuroma]] | |||
* Nerve cysts. | |||
* Neuritis ossificans. | |||
* Localized interdigital neuritis ([[Morton neuroma]]). | |||
===Degenerative changes=== | ===Degenerative changes=== | ||
Types:<ref>URL: [http://missinglink.ucsf.edu/lm/ids_104_musclenerve_path/student_musclenerve/nervepath.html http://missinglink.ucsf.edu/lm/ids_104_musclenerve_path/student_musclenerve/nervepath.html]. Accessed on: 9 November 2010.</ref> | Types:<ref>URL: [http://missinglink.ucsf.edu/lm/ids_104_musclenerve_path/student_musclenerve/nervepath.html http://missinglink.ucsf.edu/lm/ids_104_musclenerve_path/student_musclenerve/nervepath.html]. Accessed on: 9 November 2010.</ref> | ||
* | *Axonal degeneration. | ||
* | *Wallerian degeneration. | ||
*Segmental demyelination. | *Segmental demyelination. | ||
====Axonal degeneration==== | |||
*Axonal swelling. | |||
*Intra-axonal filamentous aggregates. | |||
*Mitochondrial abnormalities. | |||
*Aggregation of organelles and dense bodies. | |||
====Wallerian degeneration==== | ====Wallerian degeneration==== | ||
*Watery axon and granular disintegration (distal). | |||
*Macrophage accumulation (3-4d after transsection). | |||
*Many lysosomes (CD68+ve). | |||
*Endoneurial proliferation. | |||
*Digestion chambers - '''key feature'''. | *Digestion chambers - '''key feature'''. | ||
Line 765: | Line 926: | ||
</gallery> | </gallery> | ||
===Regeneration=== | |||
*Axon sprouts (regenerating clusters): Three or more closely apposed myelinated axons. | |||
*Thin myelin sheaths. | |||
===Inflammation=== | |||
*[[Inflammatory pseudotumour]]. | |||
*[[Leprosy]] (Leprous neuropathy). | |||
*[[Sarcoidosis]]. | |||
*CMV neuritis in immuncompromised patients. | |||
*[[Vasculitis]]. | |||
*Paraprotein-associated neuropathy. | |||
*Neuropathy with macrophage-induced demyelination (CIDP, GBS). | |||
====Guillain–Barré syndrome==== | |||
*Acute inflammatory demyelinating polyneuropathy (AIDP) | |||
*Preceding infection (RSV, EBV, CMV, HIV, Mycoplasma). | |||
*Monophasic course of motor / sensory deficits. | |||
*Hours to 4 weeks. | |||
*Elevated CSF protein but normal cell count. | |||
*Mononuclear ednoneurial perivascular inflammatory infiltrate (mostly CD4+ve). | |||
*Destructive myelin stripping by macrophages. | |||
*Reduced fiber density. | |||
*Uncompacted myelin / Widely spaced myelin. | |||
====Chronic inflammatory demyelinating polyneuropathy (CIDP)==== | |||
*Progredient course longer than 8 weeks.<ref>URL: [http://path.upmc.edu/cases/case426.html http://path.upmc.edu/cases/case426.html]. Accessed on: 14 | |||
November 2010.</ref> | |||
*Progressive or relapsing and remitting course. | |||
*Multifocal affections of proximal nerves (motor and sensory symptoms). | |||
*Responsive to steroids. | |||
*Enlargement of affected nerve. | |||
*Variation of fiber density between fascicles / reduced axon numbers. | |||
*CD4+ve/CD8+ve inflammatory infiltrates(approx. 65% cases). | |||
*Demyelination (thinly myelinated axons, macrophages). | |||
*Onion-bulb formations (15-40%, chronic recurrent demyelination and remyelination). | |||
DDx: Familial hypertrophic neuropathy. | |||
====Neurosarcoidosis==== | |||
*Neurological symptoms in 5% of sarcoidosis cases. | |||
*Granulomas may be endoneurial or epineurial. | |||
*Compact mass of epitheloid cells. | |||
*Perilesional fibrosis and lymphocytic infiltrates. | |||
*Axonal loss and regenerating fibers. | |||
*Segmental demyelination and remyelination. | |||
====Vasculitic neuropathy==== | |||
*Endoneurial and epineurial mircrovessels, arterioles and venules. | |||
*Ischemia of nerve: thrombosis and fibrinoid necrosis. | |||
*Signs of previous vasculitis: Vessel narrowing, fragmentation of elastica, fibrous obliteration and recanalization. | |||
*Often nerve involvement in systemic vasculitis: | |||
**Medium-sized epineurial vessels: mostly classic polyarteritis nodosa. | |||
**Small and medium-sized vessels and eosinophilia: Churg-Strauss angitis. | |||
**Small vessels and necrotizing: ANCA-associated microscopic polyangitis. | |||
===Diseases=== | |||
* | <gallery> | ||
* | File:Leprosy with perineural invasion 3.jpg | leprosy with perineural invasion. H&E stain (WC/Kozhikode) | ||
** | File:Granulomatous_nerve_inflammation.jpg | Granulomatous inflammation of peripheral nerve in sarcoidosis (WC/jensflorian) | ||
</gallery> | |||
===Other Diseases=== | |||
*Amyloid neuropathy: Amorphic endoneurial deposits. | |||
**TTR amyloidosis is of specific interest, because treatment options exist.<ref>{{Cite journal | last1 = Adams | first1 = D. | last2 = Koike | first2 = H. | last3 = Slama | first3 = M. | last4 = Coelho | first4 = T. | title = Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. | journal = Nat Rev Neurol | volume = 15 | issue = 7 | pages = 387-404 | month = Jul | year = 2019 | doi = 10.1038/s41582-019-0210-4 | PMID = 31209302 }}</ref> | |||
**Example of amyloid deposits [https://www.nature.com/articles/s41582-019-0210-4/figures/3 here] | |||
*Neuropathy associated with paraproteinemia: Alterations in myelin periodicity, nerve fiber loss. | |||
**[[MGUS]] - Monoclonal gammopathy of unknown significance. | |||
** Multiple myeloma. | |||
**[[POEMS]] syndrome. | |||
**[[LCDD]] - light chain deposition diesease. | |||
*Toxic polyneuropathy (drug toxicity).<ref>URL: [http://path.upmc.edu/cases/case173.html http://path.upmc.edu/cases/case173.html]. Accessed on: 8 January 2012.</ref> | *Toxic polyneuropathy (drug toxicity).<ref>URL: [http://path.upmc.edu/cases/case173.html http://path.upmc.edu/cases/case173.html]. Accessed on: 8 January 2012.</ref> | ||
*Polyglucosan body disease. | |||
===Neoplasms=== | |||
''Main article: [[Peripheral nerve sheath tumours]]'' | |||
*Nerve sheath tumors: | |||
**[[Schwannoma]] | |||
**[[Neurofibroma]] | |||
**[[Perineurioma]] | |||
**[[Nerve sheath myxoma]] | |||
**[[Malignant peripheral nerve sheath tumour]] | |||
*Non neurogenic-tumors of the nerve: | |||
**[[Paraganglioma]] | |||
**[[Lipoma]] | |||
**[[Hemangioblastoma]] <ref>{{Cite journal | last1 = Gläsker | first1 = S. | last2 = Berlis | first2 = A. | last3 = Pagenstecher | first3 = A. | last4 = Vougioukas | first4 = VI. | last5 = Van Velthoven | first5 = V. | title = Characterization of hemangioblastomas of spinal nerves. | journal = Neurosurgery | volume = 56 | issue = 3 | pages = 503-9; discussion 503-9 | month = Mar | year = 2005 | doi = | PMID = 15730575 }}</ref> | |||
**[[Synovial sarcoma]] <ref>{{Cite journal | last1 = Scheithauer | first1 = BW. | last2 = Amrami | first2 = KK. | last3 = Folpe | first3 = AL. | last4 = Silva | first4 = AI. | last5 = Edgar | first5 = MA. | last6 = Woodruff | first6 = JM. | last7 = Levi | first7 = AD. | last8 = Spinner | first8 = RJ. | title = Synovial sarcoma of nerve. | journal = Hum Pathol | volume = 42 | issue = 4 | pages = 568-77 | month = Apr | year = 2011 | doi = 10.1016/j.humpath.2010.08.019 | PMID = 21295819 }}</ref> | |||
=See also= | =See also= |
edits